# The Campbell's Company (CPB) fundamentals

Data as of 2026-11-04. NASDAQ, United States. Sector: Consumer Defensive / Food Products. Price $21.96, market value $6.5 billion.

## Valuation
- **P/E (trailing): 16.8×** (5-yr avg 17.0×, 3-yr avg 18.1×). The Campbell's Company trades at 16.8× trailing earnings, close to its own five-year average of 17.0×. The Consumer Defensive median in the September 2026 study was 20.1×. Forward P/E is 12.0×, lower than trailing, so analysts expect earnings to grow.
- **Price / sales: 0.7×**. Each dollar of revenue is priced at 0.7×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 1.7×**. The shares trade at 1.7× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 10.5×**. Enterprise value is 10.5× operating earnings before depreciation, the multiple that ignores how the company is financed.
- **Free-cash-flow yield: 10.4%** (5-yr avg 7.4%). Free cash flow equals 10.4% of the market value, above its five-year average of 7.4%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.
- **Earnings yield: 6.0%**. The inverse of the P/E: 6.0% of the price is earned each year.

## Profitability
- **Operating margin: 8.7%**. 8.7% of revenue is left after running the business.
- **Net margin: 4.1%**. 4.1% of each dollar of sales reaches the bottom line.
- **Return on equity: 10.5%**. 10.5% on shareholders' equity is solid.
- **Return on invested capital: 6.4%**. Return on all capital, debt included, is 6.4%.
- **Return on assets: 2.6%**. Each dollar of assets produces 2.6% of profit.

## Growth
- **Revenue growth (1 yr): -5.0%** (3-yr 1.4%/yr, 5-yr 2.8%/yr). Revenue fell 5.0% over the last year, against 2.8% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): -34.8%** (3-yr -22.8%/yr, 5-yr -16.8%/yr). Earnings per share fell 34.8%, slower than revenue, so margins compressed.
- **Free-cash-flow growth (3 yr): -4.3%/yr**. Free cash flow has compounded at -4.3% a year over three years, keeping pace with earnings: the growth is real cash.

## Financial health
- **Debt to equity: 1.85**. Debt is 1.85 times equity, a leveraged balance sheet that needs steady cash flow to service.
- **Net debt / EBITDA: 5.3×**. It would take 5.3 years of operating earnings to repay net borrowings, above the 3× level most lenders treat as comfortable.
- **Current ratio: 0.82** (quick 0.82). Current liabilities exceed current assets, so the company depends on ongoing cash generation or refinancing to pay the next year's bills.
- **Altman Z-score: 1.44**. A Z-score of 1.44 is in the distress zone, a signal to examine the balance sheet closely.
- **Piotroski F-score: 6/9**. 6 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 4.55%** ($1.56 per share, trailing). The Campbell's Company yields 4.55%, an income-level yield.
- **Payout ratio: 117%** (69% of free cash flow). The dividend exceeds earnings (117% payout), though free cash flow still covers it.
- **Consecutive years of increases: 12**. 12 straight years of increases, a record that survived at least one recession.
- **Dividend growth (5 yr): 2.2%/yr** (1-yr 5.4%). The dividend has grown 2.2% a year over five years.

## Analyst view
- **Analyst consensus: hold** (17 analysts). 17 analysts cover The Campbell's Company; the consensus is hold, with an average price target of $20.79 (-5% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -22.8%** (YTD -16.5%, 3-mo -1.0%). The shares are down 22.8% over twelve months including dividends.
- **From 52-week high: -31.5%** (18.1% above the low). Trading 31% below its 52-week high, deep in a drawdown.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 66**. An RSI of 66 is neutral.
- **Beta (1 yr): -0.42** (volatility 33%). Beta of -0.42 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=CPB · Page: https://foliofundamentals.com/stocks/cpb

Not investment advice.